In DSS colitis, systemic inactivation of the Alox15 gene (Alox15−/− mice) protected female mice from the development of colitis symptoms and transgenic expression of human ALOX15 under the control of the aP2 promoter deteriorated the outcome of the disease [28]. The gene discussed is ALOX15; the disease is colitis.